Detego Global Announces 2025 Sponsorship of the South Wales Police and Falcons Rugby Teams
HORSHAM, UNITED KINGDOM / ACCESSWIRE / October 22, 2024 / Detego Global, the British company renowned for digital forensics, endpoint monitoring, and case management solutions, proudly announces its official sponsorship of the South Wales Police and Falcons Rugby teams for the second consecutive year. This exciting partnership unites cutting-edge technology with rugby teams renowned for their excellence, with the South Wales Police team having secured the prestigious British Police Cup three times in a row.
Both teams have a strong legacy of dedication, teamwork, and outstanding achievements on the pitch. Detego Global's sponsorship reflects a shared commitment to excellence and community support, with the Detego Global logo proudly displayed front and centre on the teams' jerseys.
Andy Lister, Managing Director of Detego Global, shared his enthusiasm for the partnership and the company's continued support for law enforcement:
"We are thrilled to sponsor the South Wales Police and Falcons Rugby teams. The South Wales Police team's incredible achievement of winning the British Police Cup three times in a row is a testament to their hard work, teamwork, and perseverance. As a company dedicated to empowering law enforcement through our digital and cyber solutions, it's an honour to contribute to teams that exemplify the same level of commitment and discipline on the rugby pitch."
Gareth Bishop, Director of Rugby for South Wales Police, welcomed the sponsorship, saying:
"We are excited to kick off the upcoming season with the support of Detego Global. As we continue to build on our recent successes, having a company like Detego Global backing us demonstrates that this sponsorship is not just about supporting outstanding rugby teams but also about strengthening ties with the law enforcement community. We're grateful for their support and look forward to a fantastic season."
The partnership marks an important milestone in Detego Global's ongoing "Progress Through Purpose" initiative, the cornerstone of its corporate social responsibility efforts. Detego Global actively supports law enforcement teams through these initiatives and by providing discounted training and software. Police team members involved in digital forensics are encouraged to contact the team at Detego Global to learn more about the extensive support programmes and offers on DFIR tools. The initiative also supports veterans, recognising their service and facilitating their transition into civilian careers.
In addition to these sponsorships, Detego Global has also secured a two-year deal with 4 Nations Police Rugby. With the company's logo proudly displayed on all kits worn by the competing nations, Detego Global's integral role in empowering law enforcement teams will be highlighted through this unique partnership.
The 4 Nations Police Rugby Cup features teams from the police forces of England, Scotland, Wales and Ireland competing annually in a series of matches that not only showcase the athletic prowess and teamwork among the police forces but also serve as a platform for key players to come together and form the British Police rugby team.
About Detego Global:
Detego Global is a leading provider of digital forensics, case management, and endpoint monitoring solutions. The company's pioneering Unified Digital Forensics Platform is renowned for its ability to transform investigations, providing rapid and accurate results through patented forensic imaging tools, triage capabilities, AI analytics, and workflow automation. Detego Global supports a wide range of customers in their efforts to combat serious crimes such as fraud, child abuse, organised crime, human trafficking, and terrorism, offering cutting-edge technology and unparalleled expertise. They are trusted by the military, law enforcement teams, intelligence agencies and enterprises around the world.
About South Wales Police RFC and South Wales Falcons RFC
Founded in 1969, the South Wales Police Rugby team has a long and proud history, having produced 12 full international Welsh players. The team is currently the reigning champion of the British Police Cup, winning the title an impressive six times, including three consecutive victories in recent years. The team's second side, The South Wales Falcons, plays local charity games and sevens competitions throughout the year. Both teams continue to represent the very best of police rugby, embodying the values of teamwork, dedication, and community spirit.
Company: Detego Global
Contact Person: Buddhika Karunasekara (Director of Marketing)
Phone Number: +44 (0) 7889 227 428
Email: budd.karunasekara@detegoglobal.com
Release Date: October 22, 2024
SOURCE: Detego Global
View the original press release on accesswire.com
Detego Global

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom